Genocea Biosciences reported $13.36M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Baxter International BAX:US $ 2731M 57M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Cytokinetics CYTK:US $ 74.64M 17M
Cytori Therapeutics CYTX:US $ 3.5M 924K
Genocea Biosciences GNCA:US $ 13.36M 1.19M
Glaxosmithkline GSK:US 7.14B 722M
Infinity Pharmaceuticals INFI:US $ 11.18M 585K
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Moderna Inc MRNA:US 1.41B 119M
Novavax NVAX:US $ 485.99M 157.86M
Pfizer PFE:US $ 16447M 3384M
Prothena PRTA:US 29.95M 2.17M